GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teyi Pharmaceutical Group Co Ltd (SZSE:002728) » Definitions » Scaled Net Operating Assets

Teyi Pharmaceutical Group Co (SZSE:002728) Scaled Net Operating Assets : 0.74 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Teyi Pharmaceutical Group Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Teyi Pharmaceutical Group Co's operating assets for the quarter that ended in Sep. 2024 was ¥1,891.4 Mil. Teyi Pharmaceutical Group Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥109.7 Mil. Teyi Pharmaceutical Group Co's Total Assets for the quarter that ended in Jun. 2024 was ¥2,407.8 Mil. Therefore, Teyi Pharmaceutical Group Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.74.


Teyi Pharmaceutical Group Co Scaled Net Operating Assets Historical Data

The historical data trend for Teyi Pharmaceutical Group Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teyi Pharmaceutical Group Co Scaled Net Operating Assets Chart

Teyi Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.69 0.69 0.73 0.66

Teyi Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.68 0.69 0.72 0.74

Competitive Comparison of Teyi Pharmaceutical Group Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Teyi Pharmaceutical Group Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teyi Pharmaceutical Group Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teyi Pharmaceutical Group Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Teyi Pharmaceutical Group Co's Scaled Net Operating Assets falls into.



Teyi Pharmaceutical Group Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Teyi Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1865.39-195.955)/2545.605
=0.66

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2512.637 - 647.247
=1865.39

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=501.955 - 0 - 306
=195.955

Teyi Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(1891.388-109.676)/2407.843
=0.74

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2491.27 - 599.882
=1891.388

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=749.676 - 0 - 640
=109.676

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teyi Pharmaceutical Group Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Teyi Pharmaceutical Group Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Teyi Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9, 11, Changxing Road, Taicheng, Guangdong Province, Taishan, CHN, 529200
Teyi Pharmaceutical Group Co Ltd is engaged in Research and development, production and sales of traditional Chinese medicines and chemical preparations.
Executives
Zhang Yong Zhao Executives
Chen Xi Liang Directors, Directors, and Executives
Xu Shao Hua Securities Affairs Representative
Xu Wei Gao Director
Xu Song Qing Directors, executives
Liu Guang Tao Executives
Du Yong Chun Supervisors
Huang Yan Ling Executives
Chen Guang Ting Supervisors

Teyi Pharmaceutical Group Co Headlines

No Headlines